Compare KSPI & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KSPI | ASND |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | Kazakhstan | Denmark |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2B | 16.2B |
| IPO Year | 2023 | 2014 |
| Metric | KSPI | ASND |
|---|---|---|
| Price | $104.18 | $261.09 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 16 |
| Target Price | $104.33 | ★ $281.50 |
| AVG Volume (30 Days) | ★ 664.7K | 475.4K |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | ★ 8.56% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3.90 | $96.35 |
| Revenue Next Year | $16.80 | $44.91 |
| P/E Ratio | $7.12 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $68.59 | $186.05 |
| 52 Week High | $109.94 | $282.15 |
| Indicator | KSPI | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 63.53 | 57.96 |
| Support Level | $69.92 | $238.09 |
| Resistance Level | N/A | $260.91 |
| Average True Range (ATR) | 3.02 | 8.01 |
| MACD | 0.01 | 0.88 |
| Stochastic Oscillator | 58.69 | 69.88 |
Kaspi.kz JSC is the payment, marketplace, and Fintech ecosystem in Kazakhstan. The firm provides interconnected technologically seamless products and services that help people to pay, shop and manage their finances. Its operating segment includes the Payments Platform that connects its customers, which consist of both consumers and merchants, to facilitate cashless, digital transactions, the Marketplace Platform, which derives maximum revenue, connects merchants and consumers enabling merchants to increase their sales and consumers to buy a broad selection of products and services offered by a variety of merchants, and Fintech Platform that enables customers to manage their personal finances online and access consumer finance and deposit products through the Kaspi.kz Super App.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.